MyFinsight
Home
Blog
About
Contact
Net income
$63,734K
Amortization of intangible
assets
$9,703K
Stock-based compensation
$6,260K
Prepaid expenses and
other current assets
-$2,449K
Inventory
-$2,236K
Reduction in the carrying
amount of right-of-use...
$77K
Depreciation
$70K
Net cash provided by
(used in) operating...
$59,587K
Canceled cashflow
$24,942K
Net increase
(decrease) in cash and cash...
$46,688K
Canceled cashflow
$12,899K
Accrued expenses and
other liabilities
-$9,207K
Change in fair value of
equity securities
$4,750K
Accounts receivable, net
$4,357K
Accounts payable
-$4,051K
Deferred taxes
$2,336K
Accretion of discount
$135K
Operating lease liability
-$106K
Proceeds from exercise of
stock options
$3,302K
Net cash provided by
(used in) financing...
-$12,872K
Net cash provided by
(used in) investing...
-$27K
Canceled cashflow
$3,302K
Repurchase of common stock
$14,574K
Purchases of property and
equipment
$27K
Payment of liabilities
arising from asset...
$1,299K
Payment of employee
withholding tax related to...
$301K
Back
Back
Cash Flow
CATALYST PHARMACEUTICALS, INC. (CPRX)
CATALYST PHARMACEUTICALS, INC. (CPRX)
source: myfinsight.com